Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hi Runners123
You said "Company is NOT authorized to do more than 1 for 8. They will have to figure something else out to avoid delisting."
Is there a link to confirm this?
Thanks
Hundreds of posts about the warrants issue. But there may be just one explanation for stock behaviour: ZoptEC.
No institutions + No partnership + No bank risk + No milestones interest= 0% chance of success.
If the company had something valuable at hand there wouldnt be a cashless clause capable of driving the stock under 0,1.
Maybe a lot of us dont want to face it, but at least we have to start thinking about it.
Dear folks,
There are here too many optimistic people. Too many, because the risk is too close and the reward, if so, beyond 2016.
The future news will be the ZopEC continuation and possibly timid revenues in 3Q15. That's all. But I tell you, when I see the first revenues of this baby I will not be able to content the tears.
The financials have never been a problem for this company and things will continue this way. Cause We, the unconditional shareholders will always be there to milk the baby.
The concerning to all of us and sadly even for Dodd: the stock price. This carry us to the sep21th amendment. Was it an agreement? No, it was a warning, an emergency call. "If you, the warranters continue this way, we all are going to hell"
Why November 9th ? Why October 9th? Because December 14th? I tried to fix the pieces together, but I couldnt.
The 140% high ? A test. A drill.
Make your DD and dont trust anyone, folks.
0,1230 0,0722(142.13%) 9:59PM GMT+2 - Precio en tiempo real Nasdaq
Let see after hour without nervous fingers.
These things dont happen without a reason. Hold.
RSI steady.Stocastic good. Last half hour. This should fly.
0,1188 0,0680(133.86%) 9:37PM GMT+2 - Precio en tiempo real Nasdaq
I cant believe nobody has depth of market.
Im a spanish investor and it is very common to post it in our boards. Why here it isnt ?
Its the first time I wonder about in the nasdaq. Thats why my ignorance. Could someone explain it to me ?
keep calm. These guys are buying to stay
The market had misunderstood the consecuences of the public offering. The afterwards reaction was a hard downtrend.
Now we are in a different phase. The market again has misunderstood the dilution thing giving to it a much higher effect than it really would have.
Then, the fear to dilution is more powerful than the dilution itself in order to lower the stock price. And it is a feedback process.
The fair price should be around 0,70 until the company didnt present revenues in 2Q15. Now it should be, lets say 0,60. But the reality of a market's craziness is what we have.
thats the way i see it.
The company presented this financial trap knowing they wouldnt have anything to stop the dilution just because they wouldnt have anything to stop the stock price decline.
I really don't understand why nobody tried to inform the shareholders and sue the company.
This is like a cook that is preparing a promising meal, he is unable to get it ready and meanwhile more and more guests are entering the dining room begging for their portion. It doesnt care how yummy it would be you wont eat even a crumb. And the bill is not on the house.
Dont waste your time. Im going to summarize it. "They dont have revenues and they are very excited"
The only explanation for the recurrent company's mistakes is that the CEO is lost in a deep dream and nobody is bold enough to wake him up.
Forgetting about the AEZSs left in the path, forgetting about Ozarelix, forgetting about presenting an unripe Macrilen, forgetting a bad pondered public offering...
Still there was an opportunity for another mistake: WHERE ARE THE REVENUES ? WHERE... ARE... THE... REVENUES...?
We, the shareholders, the pipeline's believers, need some candy meanwhile we are in the waiting room.
The company started its commercial adventure in November 2014 and a single buck has entered to the box. What was "THE SALES FORCE" doing 10 long months? Was it floating in the CEO's dream?
And please Alex, dont talk me about 3 years because Im not a vampire facing a 500 years life. They have to solve it until december 2015. Come on CEO, wake up!
Im laughing about it, but the money we have lost up to now is not a joke. Its not a joke.
Warrant B cashless clause, in very simple terms, says, holders will get the following number of shares if stock price falls below 74 cents
30M (2/p -1) where p is share price, so, if share price is 20 cents p.e, then they get 30M (2/.2 -1) = 270M shares
I understand this is endless as I cant read any in reference to a limit.
My fault was not paying attention to the clause when the public offering was announced. And the SEC's fault was not obligating the company to explain in advance and clearly to the shareholders this.
No Alex, everything matters.
The communication's responsible doesn't seem to be a wise sir or madam.
We, the market, are not expecting the company to tell us they will try an strategy that we think it should have already been underway.
We, the market, are expecting what the heck happens with the OS. That's "the announcement". You must cut the uncertainty, no matter how painful it may be, in order to go on.
In fact, I would go beyond and admit the public offering set a real mess not anticipated by the company.
We, the market , want things clear and simple. Crystal clear.
Desperate steps, not because the steps itselves but the way they are announced.
Maybe it is a good decision to share intellectual property in order to strenghten continuation of the phase 3 pipeline. Seeing the situation it is a very good decision, indeed. But I would have waited until I could give a certain partner.
A great mistake of communication and I hope the market applaud the strategy and dont focus on the manner it is announced.
Thanks Gary and Jlax.
After browsing for information and seeing company's reports I realized its impossible to get a real today's picture. And I agree with you, Gary, just to wait until 2Q15. To contact the company, jlax, it was demonstrated it doesnt solve it.
This lack of transparency infringe upon shareholder's rights and if we add it to the intentional messy last public offering we are facing a management very difficult to trust in.
Maybe they have already considered the pros and cons, but the distrust introduced in the market is a fact. And as I see it, a great mistake in the long term.
When I first read the CEO profile I was convinced he was a plus to the company, now I realize he is a great minus.
A company involved in such relevant goals around cancer drugs, and so close (If we believe)shoudnt be at 0,22$. Thats an insult to the company's investigators, to the scientific community and in the last term to us, the shareholders.
From my part, I consider this topic "OS issue" ended.
PS: Lately investorhub doesnt work properly when browsing messages, at least from Europe. If someone knows how to tell the technician would be great. I was unable.
Im only interested in a data. How many outstanding shares are we facing today? Today, not yesterday, not the expected ones. And I want a linkable data, not a dubious email transcription.
Its the second time I post this question. And I hope the martial moderator not to erase it.
Its a very important data and I would be very grateful if someone post the number nobody seems to know for certain.
Just a number and a link, not a dissertation. If its not asking too much.
No Gary,
EMA just said the same FDA did. Continue folks and will see.
The 18-month period it is what the company estimated. An exercise of honesty as I see it.
Anyway, Macrilen is not the thing. Not because its time frame, not because its low-medium reward.
But we have a thing, and thats ZoptEC. Not just because it, but it probably could give a push to other drugs of their pipeline. As other AEZSs pursue similar correlated paths.
ZopEC december completion is the start or the end, there is not anymore.
edit 4542
I wanted to say:
"No. It was clear It wouldnt happen and It didnt."
Was RS a concern?
No, It was clear It would happen and it didnt. Thats why the market didnt overreact today.
What drove down the stock to so low prices?
The warrants isssue. I think too many people didnt understand the dilution effect. And in this case, the market did overreact. The management was wrong about throwing such a complex public offering to the market. And more with their past of dilutions.
What will rise the stock price in short term?
Macrilen? Nop. It has a 18 months horizon.
Estrogel and Saizen ? Maybe a bit after 2Q15. Maybe avoiding a new ATM. Not a big deal.
ZoptEC ? Normally an oncology drug in phase 3 has a 45% of success and it takes 10 years to them to reach that point. Im not going to make an educated guess here, but no one can deny its a hot thing. No one.
Editing post 4499
I put 5M short shares. I got confused with other stock. The amount is 2.8M. However, I had the idea that the amount doubled from March and in this I was right. Almost, as It was 1.5M.
There is not going to be a RS, you should know it. Instead, the company will use an extension, you may consider granted and the only way to go ahead.
The low stock price is due to 5000000 outstanding short shares, double from march. The vultures don't finish until they believe there is not anything else to eat.
What do you think about the Molycorp Silmet fire ? I don't like that kind of news.
Maybe, there is not going to be any bankruptcy.
In such case, who are the most damaged ¿ the bondholders.
Who is really going to decide about it ? the bondholders. Then..
Behind every outstanding share there is an investor that believes or hopes not such thing is going to happen. Thats why the stock price is 0,42 right now. Thats the unique reason.
An RS may not be necessary as they could apply for an extention beyond june. Anyway I wouldn't worry about an RS, it's the next "public offering of shares" what should worry us.
Besides all fears, I don't think the MMs will let go a company without debt, cash and a phase 3 completion in hand. Then at any time before year-end the stock should rise over $1 to make any sense to this game.
Sorry, if I don't get it, but the data Im wondering about is those concerning this statement "DSMB's recommendation follows 1rst interim analysis" on the press release.
There you go one.
The next step here, 1st interim Zopc phase 3 data. When would you say these data will be release?